The Investigation of Vocal Behaviors in Children With ADHD

NCT06030583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-07-25

No results posted yet for this study

Summary

The aim is to gain information about vocal hygiene knowledge level, phonotrauma behavior frequency, voice-related quality of life, and voice handicap index scores in children diagnosed with ADHD aged 8 to 11, through inter-group comparisons of scale and questionnaire data between children diagnosed with ADHD and control group participants aged 8 to 11.

Conditions

  • Voice Disorders in Children
  • Voice

Interventions

OTHER

Scales and Forms

This study does not involve any interventions. Information will be collected from the study group and the control group through scales and forms.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Esra Özcebe, Professor · Istanbul University- Cerrahpaşa, Audiology Department

  • Fatma Esen Aydınlı, Assoc. Prof. · Hacettepe University, Speech and Language Therapy Departmant

  • Özlem Beşik Topçu, SLP · Hacettepe University, Speech and Language Therapy

  • Meltem Çiğdem Kirazlı, Ph.D. · Hacettepe University, Speech and Language Therapy

  • Nur Seda Saban Dülger, SLP · Hacettepe University, Speech and Language Therapy

  • Merve Öğülmüş Uysal, SLP · Hacettepe University, Speech and Language Therapy

  • Halime Tuna Çak Esen, Assos. Prof. · Independent Researcher

  • Cihan Aslan, Dr. · Hacettepe University Faculty of Medicine Department of Pediatric Mental Health And Diseases

Eligibility

Min Age
8 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06030583 on ClinicalTrials.gov